Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
The Lancet. Infectious Diseases
|
April 24, 2018
Urban transmission of tuberculosis in China
Peter M Keller
The Lancet. Infectious Diseases
|
March 18, 2020
Think tuberculosis-but is thinking enough?
Peter M Keller, Hansjakob Furrer
Viszeralmedizin
|
August 20, 2015
Rational Therapy of Clostridium difficile Infections
Peter M Keller, Marko H Weber
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Rapid identification of NDM-, KPC-, IMP-, VIM- and OXA-48-like carbapenemase-producing Enterobacteriales from blood cultures by a multiplex lateral flow immunoassay
Elias Bodendoerfer, Peter M Keller, Stefano Mancini
Journal of Clinical Microbiology
|
January 15, 2016
Restricted Identification of Clinical Pathogens Categorized as Biothreats by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
Peter M Keller, Vera Bruderer, Franco Müller
Current Opinion in Pulmonary Medicine
|
February 27, 2022
Drug-resistant tuberculosis: advances in diagnosis and management
Gunar Günther, Nunurai Ruswa, Peter M Keller
BMC Microbiology
|
July 19, 2008
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
Peter M Keller, Erik C Böttger, Peter Sander
The New England Journal of Medicine
|
January 14, 2011
Rapid molecular detection of tuberculosis
Andrea Zbinden, Peter M Keller, Guido V Bloemberg
The Journal of Antimicrobial Chemotherapy
|
August 18, 2016
Comment on: Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system
Frank Imkamp, Peter M Keller, Erik C Böttger
World Journal of Gastroenterology
|
September 19, 2019
Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencing
Daniel Pohl, Peter M Keller, Valentine Bordier, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
The Lancet. Infectious Diseases
|
April 24, 2018
Urban transmission of tuberculosis in China
Peter M Keller
The Lancet. Infectious Diseases
|
March 18, 2020
Think tuberculosis-but is thinking enough?
Peter M Keller, Hansjakob Furrer
Viszeralmedizin
|
August 20, 2015
Rational Therapy of Clostridium difficile Infections
Peter M Keller, Marko H Weber
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Rapid identification of NDM-, KPC-, IMP-, VIM- and OXA-48-like carbapenemase-producing Enterobacteriales from blood cultures by a multiplex lateral flow immunoassay
Elias Bodendoerfer, Peter M Keller, Stefano Mancini
Journal of Clinical Microbiology
|
January 15, 2016
Restricted Identification of Clinical Pathogens Categorized as Biothreats by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
Peter M Keller, Vera Bruderer, Franco Müller
Current Opinion in Pulmonary Medicine
|
February 27, 2022
Drug-resistant tuberculosis: advances in diagnosis and management
Gunar Günther, Nunurai Ruswa, Peter M Keller
BMC Microbiology
|
July 19, 2008
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
Peter M Keller, Erik C Böttger, Peter Sander
The New England Journal of Medicine
|
January 14, 2011
Rapid molecular detection of tuberculosis
Andrea Zbinden, Peter M Keller, Guido V Bloemberg
The Journal of Antimicrobial Chemotherapy
|
August 18, 2016
Comment on: Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system
Frank Imkamp, Peter M Keller, Erik C Böttger
World Journal of Gastroenterology
|
September 19, 2019
Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencing
Daniel Pohl, Peter M Keller, Valentine Bordier, et al.
Page
of 11